Q1 2026 Holdings
Filed 2026-05-15 | 42 holdings | $435.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $31.5M | 374,000 | 7.2% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $31.2M | 1,750,000 | 7.2% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $25.1M | 4,215,930 | 5.8% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $24.3M | 1,750,000 | 5.6% |
| Immunitybio Inc(IBRX)Put | COM | 45256X103 | $23.0M | 3,000,800 | 5.3% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $22.8M | 316,453 | 5.2% |
| Sol-Gel Technologies LTD(SLGL) | SHS NEW | M8694L137 | $21.7M | 274,363 | 5.0% |
| Alumis Inc(ALMS) | COM | 022307102 | $18.9M | 856,061 | 4.3% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $16.1M | 220,000 | 3.7% |
| Annexon Inc(ANNX) | COM | 03589W102 | $13.9M | 2,500,000 | 3.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $13.6M | 675,000 | 3.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $13.6M | 545,625 | 3.1% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $13.6M | 964,462 | 3.1% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $10.5M | 800,198 | 2.4% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $10.2M | 524,066 | 2.4% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $10.1M | 500,000 | 2.3% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $9.3M | 500,000 | 2.1% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $9.1M | 1,334,130 | 2.1% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $9.0M | 183,330 | 2.1% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $8.7M | 1,200,000 | 2.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $8.0M | 199,348 | 1.8% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $7.5M | 325,000 | 1.7% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $7.4M | 300,000 | 1.7% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $7.1M | 1,350,000 | 1.6% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $6.9M | 7,554,347 | 1.6% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $6.0M | 3,405,757 | 1.4% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $5.9M | 2,238,496 | 1.3% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $5.9M | 842,106 | 1.3% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $5.4M | 1,020,489 | 1.2% |
| Unicycive Therapeutics Inc(UNCY) | COM NEW | 90466Y202 | $5.2M | 796,558 | 1.2% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $5.2M | 327,307 | 1.2% |
| Promis Neurosciences Inc(PMN) | COM SHS | 74346M505 | $4.7M | 371,402 | 1.1% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $4.3M | 300,000 | 1.0% |
| Immix Biopharma Inc(IMMX) | COM | 45258H106 | $3.2M | 350,000 | 0.7% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $2.9M | 951,809 | 0.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $2.3M | 82,800 | 0.5% |
| Humacyte Inc(HUMA) | COM | 44486Q103 | $2.3M | 3,750,000 | 0.5% |
| Galectin Therapeutics Inc(GALT)Call | COM NEW | 363225202 | $2.2M | 800,000 | 0.5% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $1.9M | 124,666 | 0.4% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.8M | 50,000 | 0.4% |
| Anavex Life Sciences Corp(AVXL)Call | COM NEW | 032797300 | $1.6M | 521,300 | 0.4% |
| Opus Genetics Inc(IRD) | COM | 67577R102 | $1.5M | 324,340 | 0.3% |